News
EKSO
0.8871
+3.63%
0.0311
Ekso Bionics Holdings Price Target Cut to $2.00/Share From $2.50 by Lake Street
Dow Jones · 3d ago
Ekso Bionics Holdings Is Maintained at Buy by Lake Street
Dow Jones · 3d ago
Lake Street Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $2
Benzinga · 3d ago
Ekso Bionics price target lowered to $2 from $2.50 at Lake Street
TipRanks · 3d ago
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 3d ago
Ekso Bionics Holdings Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 3d ago
Ekso Bionics Holdings Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co.
Dow Jones · 3d ago
HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9
Benzinga · 3d ago
Ekso Bionics price target lowered to $9 from $10 at H.C. Wainwright
TipRanks · 3d ago
EKSO BIONICS HOLDINGS INC <EKSO.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $9 FROM $10
Reuters · 3d ago
Ekso Bionics Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary
Reuters · 3d ago
Ekso Bionics: Quarterly report
Press release · 4d ago
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
NASDAQ · 4d ago
Ekso Bionics Holdings Q3 EPS $(0.10), Inline, Sales $4.13M Miss $5.55M Estimate
Benzinga · 4d ago
Ekso Bionics Holdings GAAP EPS of -$0.10 in-line, revenue of $4.13M misses by $1.42M
Seeking Alpha · 4d ago
Ekso Bionics reports Q3 EPS (10c), consensus (10c)
TipRanks · 4d ago
*Ekso Bionics Holdings 3Q Loss/Shr 10c >EKSO
Dow Jones · 4d ago
Press Release: Ekso Bionics Announces Third Quarter 2024 Financial Results
Dow Jones · 4d ago
*Ekso Bionics Holdings 3Q Rev $4.13M >EKSO
Dow Jones · 4d ago
Press Release: Ekso Bionics Announces Third -2-
Dow Jones · 4d ago
More
Webull provides a variety of real-time EKSO stock news. You can receive the latest news about Ekso Bionics through multiple platforms. This information may help you make smarter investment decisions.
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.